维普期刊资源整合服务平台（V6.5）

147篇 您的检索式：作者名="FIGLIN RA"

选中清除导出查看参考文献查看引证文献引用追踪共8页首页上一页第1页下一页末页 /8 跳转

	题名	作者	年代	出处	被引量
1	Tumor response to combination celecoxib and erlotinib therapy in non-small cell lung cancer is associated with a low baseline matrix metalloproteinase-9 and a decline in serum-soluble E-cadherin显示文摘	Reckamp KL Gardner BK Figlin RA	2008	J Thorac Oncol2008，3，2：	1
2	Bevacizttmab with or without erlotinib in metastatic renal cell carcinoma(RCC)显示文摘	Bukowskl RM Kabbinavar F Figlin RA	2006	J Clin Oncol2006，24，18：	1
3	Supportive care versus supportive care and chemotherapy in metastatic nonsmall cell lung cancer: Doses chemotherapy make a difference?显示文摘	Figlin RA Haskell CM	1998	Cancer1998，6，1：	1
4	Phosphatidylinositol - 3 - kinase/Akt signaling pathway and kidney cancer, and the therapeutic potential of phosphatidylinositol - 3 - kinase/Akt inhibitors 显示文摘	Porta C Figlin RA	2009	J Urol2009，182，6：	1
5	A novel personalized vaccine approach in combina- tion with targeted therapy in advanced renal cell carcinoma显示文摘	FIGLIN RA	2014	Immunotherapy2014，6，3：	1
6	Surveillance following radical or partial nephrectomy for renal cell carcinoma显示文摘	LAM JS LEPPERT JT FIGLIN RA	2005	Curr Urol Rep2005，6，：	1
7	Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and man- agement of recurrent disease显示文摘	Janzen NK Kim HL Figlin RA	2003	Urol Clin North Am2003，30，4：	1
8	The role of molecular markers in the staging of renal cell carcinoma显示文摘	Leppert JT Pantuck A J Figlin RA	2007	BJU Int2007，99，5：	1
9	Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease 显示文摘	Janzen NK Kin HL Figlin RA	2003	Urol Clin North Am2003，30，：	1
10	Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease显示文摘	JANZEN NK KIM HL FIGLIN RA	2003	Urol Clin North Am2003，30，：	1
11	Safety and efficacy results of the advanced renal cell carcinoma sorafenih expanded access program in North America 显示文摘	Stadler WM Figlin RA McDermott DF	2010	Cancer2010，116，5：	1
12	Estimating the quality of life in a clinicl trial of patients with metastatic lung cancer using the Karnofsky performance status and the Functional Living Index-Cancer 显示文摘	Ganz PA Haskell CM Figlin RA	1988	Cancer1988，61，4：	1
13	Randomized phase Ⅱ study of erlotinib combined with bevacizumab compared with bevacizumab alone in metastatic renal cell cancer 显示文摘	Bukowski BM Kabbinavar FF Figlin RA	2007	J Clin Oncol2007，25，29：	1
14	Randomized phase Ⅱ study of erlotinib combined with bevacizumab compared with bevacizumab alone in metastatic renal cell cancer显示文摘	Bukowski RM Kabbinavar FF Figlin RA	2007	J Clin Oncol2007，25，29：	1
15	Surveillance after radical or partial nephrectomy for localized renal cell carcino- ma and management of recurrent disease显示文摘	Janzen NK Kim HL Figlin RA	2003	Urol Clin North Am2003，30，4：	1
16	Surveillance after radi- cal or partial nephreetomy for localized renal cell carcinoma and management of recurrent disease 显示文摘	Janzen NK Kim HI Figlin RA	2003	Urol Clin North Am2003，30，4：	1
17	Analysis of PTEN and HIF-lalpha and correlation with efficacy in patients with ad- vanced renal cell carcinoma treated with temsirolimus versus in- terferon-alpha 显示文摘	Figlin RA de Souza P McDermott D	2009	Cancer2009，115，16：	1
18	Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma 显示文摘	Motzer R J Bukowski RM Figlin RA	2008	Cancer2008，113，7：	1
19	Chemokines as therapeutic targets in renal cell carcinoma显示文摘	Reckamp KL Stricter RM Figlin RA	2008	Expert Rev Anticancer Ther2008，8，6：	1
20	Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease显示文摘	Janzen NK Kim HL Figlin RA	2003	Urol Clin North Am2003，30，4：	1

返回顶部每页显示：

共8页首页上一页第1页下一页末页 /8 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示